Paper Review Records
全部论文审稿周期
16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
38
天
Pooled safety analysis of lurbinectedin plus irinotecan in patients with advanced solid tumors
作者
Alejandro Falcón; Gregory M. Cote; Javier Molina-Cerrillo; Axel Le Cesne; Pedro Rocha; Bruno Bockorny; David Paez; Javier Martin-Broto; Sant P. Chawla; Sara Martinez; Carmen Kahatt; Vicente Alfaro; Mariano Siguero; Javier Jimenez; Ana Custodio; Vicente Alonso-Orduña; Carlos López; Attila Kollár; Juan José Soto-Castillo; Luis Paz-Ares展开收起
作者单位
1. Medical Oncology Department, Hospital Universitario Virgen del Rocio, Seville, Spain; 2. Servicio de Oncología Médica, Hospital Universitario Virgen del Rocio, Seville, Spain; 3. Medical Oncology Department, Mass General Brigham Cancer Institute, Boston, USA; 4. Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain; 5. Medical Oncology Department, Institute Gustave Roussy, Villejuif, France; 6. Medical Oncology Department, Vall d’ Hebrón University Hospital, Barcelona, Spain; 7. Medical Oncology Department, Beth Israel Deaconess Medical Center, Boston, USA; 8. Medical Oncology Department, Sant Pau, CIBERER, Barcelona, Spain; 9. Medical Oncology Department, Fundación Jiménez Díaz University Hospital General de Villalba, and Instituto deInvestigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJDUAM), Madrid, Spain; 10. Sarcoma Oncology Research Center, Santa Monica, USA; 11. Clinical R&D, Pharma Mar, Colmenar Viejo, Madrid, Spain; 12. Medical Oncology Department, Hospital Universitario La Paz, Madrid, Spain; 13. Medical Oncology Department, Hospital Universitario Miguel Servet, Saragossa, Spain; 14. Medical Oncology Department, Hospital Universitario Marqués de Valdecilla, IDIVAL, UNICAN, Santander, Spain; 15. Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; 16. Medical Oncology Department, START Madrid CIOCC, Hospital Universitario HM Sanchinarro, Madrid, Spain; 17. Medical Oncology Department, Hospital Universitario, Madrid, Spain展开收起
34
天
Class-level DILI saturation and hERG-driven risk stratification among 2024–2025 FDA-approved kinase inhibitors: an in silico multi-platform safety analysis
作者
Nihan Küçük Yılmaz; Veysel Baskın展开收起
作者单位
1. Department of Medical Pharmacology, Faculty of Medicine, Yalova University, Yalova, Turkey; 2. Department of Medical Pharmacology, Faculty of Medicine, Hitit University, Çorum, Turkey展开收起
34
天
Hedgehog Inhibitor and Paclitaxel: A Phase I Trial of the Oral Hedgehog inhibitor Taladegib in Combination with Weekly Paclitaxel in Patients with Advanced Solid Tumours
作者
Rosalind Glasspool; Sarah Patricia Blagden; Michelle Lockley; Elaine McCartney; Carol Evans; Fiona Thomson; Jennifer Brown; Laura Spiers; Chantevy Pou; Liz-Anne Lewsley; Iain A. McNeish; T.R. Jeffry Evans展开收起
作者单位
1. Beatson West of Scotland Cancer Centre and School of Cancer Sciences, University of Glasgow, Glasgow, UK; 2. Early Phase Clinical Trials Unit, Churchill Hospital, Oxford University Hospitals, Oxford, UK; 3. Centre for Cancer Centre for Cancer Evolution, Barts Cancer Institute, Queen Mary University of London, London, UK; 4. Cancer Division, University College London Hospital, London, UK; 5. Glasgow Oncology Clinical Trials Unit, University of Glasgow, Glasgow, UK; 6. The Translational Pharmacology & Immunology Laboratory, School of Cancer Sciences, University of Glasgow, Glasgow, UK; 7. Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK展开收起
37
天
Prostate cancer cells’ growth is decreased by novel MYC inhibitors
作者
Bita Nickkholgh; Joseph McGrath; Sivanandane Sittadjody; Jay Chauhan; Kwan-Young Jung; Steven Fletcher; K. C. Balaji展开收起
作者单位
1. Wake Forest Institute for Regenerative Medicine (WFIRM), Wake Forest University School of Medicine, Winston-Salem, USA; 2. Department of Physiology-Pharmacology, Wake Forest University School of Medicine, Winston-Salem, USA; 3. Department of Urology, University of FL College of Medicine – Jacksonville, Jacksonville, USA; 4. Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, USA展开收起
126
天
Spatial blueprint of colorectal cancer identifies Hypoxic CAF program that orchestrates Go-or-Grow decisions and predicts outcomes
作者
Mingkai Chen; Juan Yang; Jin Wang; Guangrun Du; Lida Zhang展开收起
作者单位
1. Department of Gastroenterology, Fuwai Central China Cardiovascular Hospital, Zhengzhou, China; 2. Department of Gastroenterology, Zhengzhou Yihe Hospital Affiliated to Henan University, Zhengzhou, China展开收起
160
天
Recent progress of dendritic cell-derived exosomes in tumor immunotherapy
作者
Baiyan Wang; Yirui Hu; Yujia Zhou; Qianqian Han; Yu Huang; Yuanhang Dong; Yike Zhang; Zixuan Guo; Xuan Zhang; Shuying Feng展开收起
作者单位
1. Medical College, Henan University of Chinese Medicine, Zhengzhou, China; 2. Henan Engineering Research Center for Chinese Medicine Foods for Special Medical Purpose, Zhengzhou, China展开收起
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
